John Bower

Louise Young is a Senior Medical Manager at the pharmaceutical company Eisai Australia Pty Ltd and responsible for Medical Affairs within the Oncology Division, working within multiple solid tumour streams. Louise has worked within the Life Sciences arena in Australia both in academia and industry for the last ten years after completing a PhD in Immunology at The Walter and Eliza Hall Institute of Medical Research.

Abstracts this author is presenting:

A phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results — Poster Session 1
Single-agent dose-finding cohort of a phase 1/2 study of lenvatinib in children and adolescents with refractory or relapsed solid tumors — Poster Session 1
Phase 3 trial of lenvatinib (LEN) vs sorafenib (SOR) in first-line treatment of patients (pts) with unresectable hepatocellular carcinoma (uHCC) — Poster Session 1

John Bower Clinical Oncology Society of Australia Annual Scientific Meeting 2017

John Bower

Abstracts this author is presenting: